Allan Halpern
Program Director · New York Presbyterian Hospital
Credentials: · · · · ·
History
- Present
Dermatology Service Division · New York Presbyterian Hospital
- 1981–1982
1977–1981
Research
Model predicting survival in stage I melanoma based on tumor progression
Journal of the National Cancer Institute · 1989 · Last of 8 authors · 1,020 citations
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet
Review · Journal of the American Academy of Dermatology · 2003 · 720 citations
Review · Nature Reviews Disease Primers · 2015 · 508 citations
- AM
120 papers
47 papers · 30 as a resident
36 papers · 2 as a resident
- KB
32 papers
26 papers
- DG
22 papers
- MW
20 papers
- KN
16 papers
Grants
- 2024–2029
ISIC-REPO; ISIC Skin Imaging Repository Enhancements for Promoting Interoperability and Utilization
National Cancer Institute · U24
Contact PI · $2.1M · Sloan-Kettering Inst Can Research
- 2003–2015
The Framingham School Study of Nevi in Children Sonic Ii
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $6.6M · Sloan-Kettering Inst Can Research
- 2003–2009
The Framingham School Study of Nevi in Children: Sonic Ii
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R56
Contact PI · $477.1K · Sloan-Kettering Inst Can Research
- 2000–2002
Prediction and Modification of Melanoma Risk
National Cancer Institute · P01
Project lead · $201.1K · University of Pennsylvania
Clinical trials
- 2017–2025
Risk Stratification Among Individuals Who Have Many Moles on Their Skin
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
- 2008–2009
In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis
Principal investigator · Completed
Lucid, Inc.
- 2006–2013
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center